|
|
Substance Name: Mecobalamin [USAN:INN:BAN:JAN]
RN: 13422-55-4
UNII: BR1SN1JS2W
InChIKey: ZFLASALABLFSNM-QBOHGLHMSA-L
Classification Codes
- Antiviral (COVID-19)
- Reproductive Effect
- Tumor Data
- Vitamin (Hematopoietic)
Molecular Formulas
- C63-H91-Co-N13-O14-P
- C63-H91-N13-O14-P.Co
Molecular Weight
- 1344.3959
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Mecobalamin
- Mecobalamin [USAN:INN:BAN:JAN]
- Methylcobalamin
Synonyms
- Algobaz
- Cobaday
- Cobalt-methylcobalamin
- Cobamet
- Cobametin
- E0302
- EINECS 236-535-3
- MBL-A
- Mecobalamin
- Mecobalamina
- Mecobalamina [INN-Spanish]
- Mecobalamine
- Mecobalamine [INN-French]
- Mecobalaminum
- Mecobalaminum [INN-Latin]
- Methycobal
- Methyl b12
- Methyl cobalamine
- Methyl vitamin B12
- Methyl-B12
- Methylcobalamin
- UNII-BR1SN1JS2W
- Vancomin
Systematic Names
- Cobinamide, Co-methyl deriv., hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
- Cobinamide, Co-methyl derivative, hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
- Cobinamide, cobalt-methyl derivative, hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
- Mecobalamin
Registry Numbers
CAS Registry Number
- 13422-55-4
FDA UNII
- BR1SN1JS2W
Other Registry Numbers
- 13870-88-7
- 15417-95-5
- 15550-62-6
- 19709-17-2
- 23319-80-4
- 35-09-6
System Generated Number
- 0013422554
Molecular Formulas
Molecular Formulas
- C63-H91-Co-N13-O14-P
- C63-H91-N13-O14-P.Co
Molecular Formula Fragments
- C63-H91-N13-O14-P
- Co
- COMPONENT
Structure Descriptors
InChI
InChI=1S/C62H90N13O14P.CH3.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);1H3;/q;-1;+3/p-2/t31-,34+,35+,36+,37-,41+,52+,53+,56+,57-,59+,60-,61-,62-;;/m0../s1InChIKey
ZFLASALABLFSNM-QBOHGLHMSA-LSmiles
[CH3-].[Co+3].C[C@@H](CNC(=O)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD | intravenous | > 200mg/kg (200mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 3939, 1988. | |
mouse | LD50 | intraperitoneal | > 5gm/kg (5000mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 529, 1970. | |
mouse | LD50 | oral | > 5gm/kg (5000mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 529, 1970. | |
mouse | LD50 | subcutaneous | > 5gm/kg (5000mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 529, 1970. | |
rabbit | LD50 | intravenous | > 75mg/kg (75mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 529, 1970. | |
rat | LD50 | intraperitoneal | > 5gm/kg (5000mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 529, 1970. | |
rat | LD50 | oral | > 5gm/kg (5000mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 529, 1970. | |
rat | LD50 | subcutaneous | > 5gm/kg (5000mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 529, 1970. |